Parkinson disease new treatment strategies Recent interest novel approaches treatment Parkinson disease-medications disease progression cerebral transplantation recent studies selegiline halt progression recent-onset Parkinson disease data use drug new patients reasonable data medication patients advanced Parkinson disease current focus excessive oxidative stress causative factor investigators patients antioxidant tocopherol vitamin clinical evidence effectiveness current multicenter study results next years High-dose vitamin U/d number months harmless reasonable patients over-the-counter compound definitive evidence available antioxidant means progression Parkinson disease studies clinical effectiveness studies issue patients Parkinson disease excitement favorable results adrenal-brain transplantation failure numerous institutions original dramatic success mild moderate improvement subsequent patients adrenal-brain transplantation improvement sufficient risk expense surgery 